Wells Fargo’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Wells Fargo's PHAT Position: Q3 2026 in Review
Wells Fargo reduced its Phathom Pharmaceuticals (PHAT) stake by 20% in Q3 2026, selling an estimated $289K and leaving 121,354 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.
Wells Fargo first reported a position in PHAT in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.65M in Q2 2026. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Wells Fargo held 121,354 shares of Phathom Pharmaceuticals worth $886K as of Q3 2026.
- Wells Fargo sold 30,648 Phathom Pharmaceuticals shares in Q3 2026, an estimated $289K.
- Phathom Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #3842 holding.
- Wells Fargo first reported a position in Phathom Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
- Wells Fargo's Phathom Pharmaceuticals position peaked at $1.65M in Q2 2026.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.